| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.7 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.7 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | 0.025 | 0.8 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |